Hims & Hers Health, Inc. (NYSE:HIMS) experienced a 12.36% drop in stock price on Tuesday, closing at $55.52 per share due to lower-than-expected revenues in the second quarter.

Although revenues grew by 73% to $544.8 million, missing analyst estimates of $552 million, net income more than tripled to $42.5 million in the same period.

For the first six months, net income surged by 277% to $91.99 million, and revenues increased by 90% to $1.13 billion year-on-year.

Looking ahead, Hims & Hers Health, Inc. (NYSE:HIMS) aims to achieve $570 million to $590 million in revenues for the third quarter and $2.3 billion to $2.4 billion for the full year.

CEO Andrew Dudum highlighted the company’s success in providing personalized, high-quality care and expressed confidence in their model benefiting customers’ health.

While HIMS shows potential as an investment, some AI stocks offer greater returns with less risk. For those seeking a low-cost AI stock with high potential and tariff benefits, explore Insider Monkey’s report on the best short-term AI stock.

Read more at Yahoo Finance: Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues